| Metalloprotease type III effectors that specifically cleave JNK and NF‐κB K Baruch, L Gur‐Arie, C Nadler, S Koby, G Yerushalmi, Y Ben‐Neriah, ... The EMBO journal 30 (1), 221-231, 2011 | 230 | 2011 |
| Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response O Yogev, O Yogev, E Singer, E Shaulian, M Goldberg, TD Fox, O Pines PLoS biology 8 (3), e1000328, 2010 | 221 | 2010 |
| Metabolic engineering against the arginine microenvironment enhances CAR-T cell proliferation and therapeutic activity L Fultang, S Booth, O Yogev, B Martins da Costa, V Tubb, S Panetti, ... Blood, The Journal of the American Society of Hematology 136 (10), 1155-1160, 2020 | 106 | 2020 |
| DNA damage–dependent translocation of B23 and p19ARF is regulated by the Jun N-terminal kinase pathway O Yogev, K Saadon, S Anzi, K Inoue, E Shaulian Cancer research 68 (5), 1398-1406, 2008 | 62 | 2008 |
| Jun proteins are starvation-regulated inhibitors of autophagy O Yogev, R Goldberg, S Anzi, O Yogev, E Shaulian Cancer research 70 (6), 2318-2327, 2010 | 53 | 2010 |
| Macrophage-derived IL1β and TNFα regulate arginine metabolism in neuroblastoma L Fultang, LD Gamble, L Gneo, AM Berry, SA Egan, F De Bie, O Yogev, ... Cancer research 79 (3), 611-624, 2019 | 51 | 2019 |
| In Vivo Modeling of Chemoresistant Neuroblastoma Provides New Insights into Chemorefractory Disease and Metastasis O Yogev, GS Almeida, KT Barker, SL George, C Kwok, J Campbell, ... Cancer research 79 (20), 5382-5393, 2019 | 43 | 2019 |
| Induction of transcriptionally active Jun proteins regulates drug-induced senescence O Yogev, S Anzi, K Inoue, E Shaulian Journal of biological chemistry 281 (45), 34475-34483, 2006 | 38 | 2006 |
| eIF4EBP3L acts as a gatekeeper of TORC1 in activity-dependent muscle growth by specifically regulating Mef2ca translational initiation O Yogev, VC Williams, Y Hinits, SM Hughes PLoS biology 11 (10), e1001679, 2013 | 37 | 2013 |
| p53 loss in MYC-driven neuroblastoma leads to metabolic adaptations supporting radioresistance O Yogev, K Barker, A Sikka, GS Almeida, A Hallsworth, LM Smith, Y Jamin, ... Cancer research 76 (10), 3025-3035, 2016 | 36 | 2016 |
| Indisulam targets RNA splicing and metabolism to serve as a therapeutic strategy for high-risk neuroblastoma A Nijhuis, A Sikka, O Yogev, L Herendi, C Balcells, Y Ma, E Poon, ... Nature Communications 13 (1), 1380, 2022 | 34 | 2022 |
| Jun proteins inhibit autophagy and induce cell death O Yogev, E Shaulian Autophagy 6 (4), 566-567, 2010 | 23 | 2010 |
| Establishment of In VivoIn Vivo Acquired Resistance to Chemotherapy Via Individual Dose Escalation Treatment Regime KT Barker, O Yogev Cancer Drug Resistance: Methods and Protocols, 73-83, 2022 | | 2022 |
| Macrophage IL-1B and TNF-a create an immune-metabolic loop regulating Arginase2 in neuroblastoma L Fultang, LD Gamble, L Gneo, AM Berry, SA Egan, F De Bie, O Yogev, ... Cancer Research, 2018 | | 2018 |
| Potential of PET imaging to monitor upregulation of NET-1 transporter SM Turnock, DR Turton, DM Ciobota, O Yogev, L Chesler, T Wilson, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 44, S410-S410, 2017 | | 2017 |
| The Roles of Jun Proteins in Determining the Fate of Cells Exposed to Environmental and Metabolic Stresses O Yogev Hebrew University, 2010 | | 2010 |
| Raf Signaling O Yogev, GS Almeida, KT Barker, SL George, C Kwok, J Campbell, ... | | |
| Macrophage-derived IL-1? and TNF-? regulate arginine metabolism in neuroblastoma SA Burchill, DS Ziegler, HC Etchevers, MD Norris, PN Cheng, ... Cancer Research 79 (3), 0 | | |
